Alet Pharmaceuticals

Alet Pharmaceuticals is a Greek pharmaceutical company specializing in the development, marketing, and distribution of branded generic medicines. Founded in 2006 and headquartered in Athens, the company offers a diverse portfolio of products across therapeutic areas such as psychiatry, neurology, cardiology, and gastroenterology. Alet was acquired by Specifar Pharmaceuticals in 2011, which subsequently became part of Watson Pharmaceuticals (later Actavis and now Teva Pharmaceutical Industries). Today, it operates as a key subsidiary within the Teva network, maintaining a strong commercial presence in the Greek healthcare market through an extensive sales force and a wide range of affordable generic treatments. Its portfolio includes well-known generic versions of treatments for depression, hypertension, and epilepsy.